Devices, methods and kits for delivery of therapeutic materials to a pancreas
Devices and methods are described herein for engraftment of stem cells into a pancreas using an endovascular approach. Targeted intra-arterial injection of stem cells selectively in a splenic artery can achieve engraftment of insulin producing cells in the tail of the pancreas with high efficiency and without systemic circulation of these cells to other organs. In one embodiment, a catheter device includes expandable occlusion elements in the form of inflatable balloons that can be used to isolate a proximal and distal end of a pancreatic portion of the splenic artery. In another embodiment, the occlusion elements include a filter element instead of a balloon. In some embodiments, targeted delivery of stem cells to the pancreatic tail can be achieved for treatment of, for example, diabetes. In some embodiments, an arterial section of the splenic artery can be isolated for selective perfusion of therapeutic cells/drugs to the tail of the pancreas.
1. A method, comprising:
introducing a catheter device into a splenic artery, the catheter device including an inner catheter, a first expandable occlusion element coupled to the inner catheter, an outer catheter defining a first lumen configured to introduce a therapeutic agent to one or more target pancreatic arteries, a second lumen configured to slidably receive at least a portion of the inner catheter, and a second expandable occlusion element coupled to the outer catheter and disposed proximally to the first occlusion element,
advancing the catheter device to a target pancreatic portion of the splenic artery;
selectively isolating a region of the target pancreatic portion of the splenic artery;
confirming isolation of at least one of a pancreatic magnum artery and a dorsal pancreatic artery; and
injecting the therapeutic agent into the isolated region.
2. The method of claim 1 , further comprising:
advancing at least a portion of the catheter device to an ostium of a celiac artery, a hepatic branch of the celiac artery or a superior mesenteric artery.
3. The method of claim 1 , further comprising:
injecting a contrast dye into the isolated region.
4. The method of claim 1 , wherein the therapeutic agent includes stem cells.
5. A method, comprising:
introducing a catheter device into a splenic artery, the catheter device including an inner catheter, a first expandable occlusion element coupled to the inner catheter, an outer catheter defining a first lumen configured to introduce a therapeutic agent to one or more target pancreatic arteries, a second lumen configured to slidably receive at least a portion of the inner catheter, and a second expandable occlusion element coupled to the outer catheter and disposed proximally to the first occlusion element,
advancing the catheter device to a target pancreatic portion of the splenic artery;
selectively isolating a region of the target pancreatic portion of the splenic artery;
injecting the therapeutic agent into the isolated region; and
inserting a guidewire through the first lumen of the outer catheter and focally perforating the splenic artery in the isolated region to increase exogenous cell penetration into pancreatic tissue.
6. The method of claim 5 , further comprising:
advancing at least a portion of the catheter device to an ostium of a celiac artery, a hepatic branch of the celiac artery or a superior mesenteric artery.
7. The method of claim 5 , further comprising:
injecting a contrast dye into the isolated region.
8. The method of claim 5 , wherein the therapeutic agent includes stem cells.